Manus Aktteva
We are only a phone call away, Call us on: +91 79 65123395
+91 79 26463395
Home
About Us Pharmaceutical Ingredients, Active Pharmaceutical Rawmaterials, API, Intermediate, Nutraceuticals, Intermediates, Speciality chemicals, Advance level intermediatesEventsNewsEnquiryContact UsResources
Manus Aktteva Biopharma LLP Biopharma LLP, An ISO 9001:2008 Certified organization, is a well informed, highly efficient and swiftly functioning competitive sourcing entity. You may please send us a sourcing request
API, Active Pharmaceutical Ingredients, Active Pharmaceutical Rawmaterials, Pharmaceutical Intermediates, Intermediates
Products A to Z
       
Search The Site
Please enter all or part of your keyword to retrive data
Search by: Chemical Name
  CAS#
  Molecular Formula
Quick Help
Services
Queries
Tel1: +91 79 65123395
Tel2: +91 79 26463395
Email: click here
Twitter  Facebook
Search Results for: B
Previous 1 - 15 | 16 - 30 | 31 - 45 | 46 - 60 | 61 - 72 | Next
1 Balofloxacin
Manus Aktteva Biopharma LLP offers Balofloxacin, 127294-70-6, for your requirements of RND along with its intermediates with supportive technical package required for evaluation for intermediates.
View Detail   |  List of Intermediates
2 Bendamustine hydrochloride
Manus Aktteva Biopharma LLP offers Bendamustine hydrochloride, 3543-75-7 for RND and its intermediates for your evaluation,pilots and commercial requirements with supportive technical package required for evaluation.
View Detail   |  List of Intermediates
3 Bepotastine besilate
Manus Aktteva Biopharma LLP offers Bepotastine besilate, 190786-44-8, for RND and intermediates for your evaluation,pilots and commercial requirements with supportive technical package required for evaluation.
View Detail   |  List of Intermediates
4 Besifloxacin
Manus Aktteva Biopharma LLP offers Besifloxacin, 141388-76-3, for your requirements of RND along with its intermediates with supportive technical package required for evaluation for intermediates.
View Detail   |  List of Intermediates
5 Betahistine dihydrochloride
Manus Aktteva Biopharma LLP offers Betahistine dihydrochloride, 5579-84-0 for your requirements of evaluation, pilots and commercials.
View Detail   |  List of Intermediates
6 Bexarotene
Manus Aktteva Biopharma LLP offers Bexarotene, 153559-49-0,for your RND and its intermediates for your evaluation,pilots and commercial requirements with supportive technical package required for evaluation.
View Detail   |  List of Intermediates
7 Biapenem
Manus Aktteva Biopharma LLP offers Biapenem, 120410-24-4 and Biapenem intermediates for your requirements of RND, evaluation, pilots and commercial along with supportive technical package required for evaluation for intermediates.
View Detail   |  List of Intermediates
8 Bicalutamide
Bicalutamide is an oral non-steroidal anti-androgen for prostate cancer. It was first launched in 1995 as a combination treatment with surgical or medical castration for advanced prostate cancer and subsequently launched as monotherapy for the treatm....
View Detail   |  List of Intermediates
9 Bimatoprost
Bimatoprost is used to control the progression of glaucoma and in the management of ocular hypertension. It reduces intraocular pressure (IOP) by increasing the outflow of aqueous fluid from the eyes.
View Detail   |  List of Intermediates
10 Bivalirudin
Bivalirudin is a short, synthetic peptide that is potent, highly specific, and a reversible inhibitor of thrombin.1,3,5 It inhibits both circulating and clot-bound thrombin5>, while also inhibiting thrombin-mediated platelet activation and aggregatio....
View Detail   |  List of Intermediates
11 Bortezomib
Bortezomib is the first therapeutic proteasome inhibitor to be tested in humans. It is approved in the U.S. for treating relapsed multiple myeloma and mantle cell lymphoma. Manus Aktteva Biopharma LLP offers Bortezomib, 179324-69-7, for RND requireme....
View Detail   |  List of Intermediates
12 Bosentan
Bosentan is a dual endothelin receptor antagonist important in the treatment of pulmonary artery hypertension. Bosentan is indicated for the treatment of pulmonary hypertension.
View Detail   |  List of Intermediates
13 Brimonidine tartrate
Brimonidine acts on receptors (alpha-receptors) in the blood vessels of the eye causing them to constrict. These blood vessels control the production of the watery fluid that fills the rear of the eye. When the blood vessels constrict there is a decr....
View Detail   |  List of Intermediates
14 Brinzolamide
Manus Aktteva Biopharma LLP offers Brinzolamide, 138890-62-7,for your RND, Pilots and commercial requirements with supportive Drug master file
View Detail   |  List of Intermediates
15 Bupropion hydrochloride
Manus Aktteva Biopharma LLP offers Bupropion hydrochloride, 31677-93-7 with USDMF, EDMF, from a GMP plant and also its intermediates, for your RND, Pilots and commercial requirements with supportive technical package required for evaluation.
View Detail   |  List of Intermediates
Previous 1 - 15 | 16 - 30 | 31 - 45 | 46 - 60 | 61 - 72 | Next
NOTE: 
  • Manus Aktteva Biopharma LLP, India is successfully representing suppliers, manufacturers from INDIA, suppliers, manufacturers from CHINA, and fulfilling the requirements of buyers from EUROPE, USA, South America, Japan, Korea, Taiwan, Australia, & middle-east.
       Keywords: New Molecules, patents, R&D, cas, cas number, product, supplier, suppliers, vendor, vendors, price, prices, api, apis, active pharmaceutical ingredient, ingredients, importer, exporter, distributor, import, export, sale, producer, manufacturer, synthesizer, synthesis, gmp, cgmp, fda, dmf, cgmp, cos, inventory, stock, prompt shipment, compounding, compound, research, development, patent, r and d, pharma
  • Please note that products falling in to controlled substance category shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.
PATENTS: 
  • => Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
        => Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
© 2017 MANUS AKTTEVA  All rights reserved..
Payment Procedure